Citicoline (Cdp-Choline) for Memory

Research suggests that citicoline may support memory function, particularly in older adults experiencing age-related cognitive decline, though the overall picture is mixed. The available evidence includes a randomized controlled trial showing improvements in episodic and composite memory scores in healthy older adults, a Cochrane meta-analysis of 14 trials finding some benefit for memory and behavior in elderly individuals with chronic cerebral disorders, a 2004 review characterizing the evidence as promising but inconclusive, and animal research demonstrating neuroprotective effects in models of memory impairment. However, a 2024 regulatory evaluation by EFSA found that only one human trial demonstrated a clear benefit and that other studies did not replicate the effect, leading the panel to conclude that a definitive cause-and-effect relationship has not been established. Studies in this area are generally limited by short durations, heterogeneous designs, and populations that vary considerably in age and baseline cognitive status, meaning that stronger and more consistent evidence is still needed before firm conclusions can be drawn.